NICE Requests More Data On Aripiprazole For Schizophrenia
Links shared publicly online about this topic.
- 883total visits
NICE Requests More Data On Aripiprazole For Schizophrenia
View full resource at medicalnewstoday.com
Tags: Bipolar Disorder Medication, Schizophrenia, Schizophrenia Medication, Antipsychotic Medication, Psychotic Disorder, Abilify, Bristol-Myers Squibb
Most Recently Shared on September 10, 2010 at 9:02 pm By:
NICE Requests More Data On Aripiprazole For Schizophrenia http://mnt.to/3JBh #regulatory
Also Shared By:
NICE Requests More Data On Aripiprazole For Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “In draft guidance , published today (10 September 2010), NICE has asked Bristol-Myers Squibb and Otsuka Pharmaceuticals to provide more data on the effectiveness of their product, aripiprazole (Abilify), as a treatment for schizophrenia in people aged 15 to 17 years. This draft guidance has been issued for consultation and the manufacturer now has an opportunity to respond to the independent Appraisal Committee's considerations and requests...” View full resource at qualitypointtech.net
Most Recently Shared on September 11, 2010 at 5:12 am By:
NICE Requests More Data On Aripiprazole For Schizophrenia: In draft guidance , published today (10 September 2010)... http://bit.ly/cp0fpF
Advertisement
MNT Schizophrenia
@mnt_schizophren
NICE Requests More Data On Aripiprazole For Schizophrenia http://mnt.to/3JBh #schizophrenia
1 year ago...